instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated enterocolitis'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated lung disease'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion related hypersensitivity reaction'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urosepsis'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasculitis'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
What was the administration route of drug 'NIVOLUMAB'? | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
What was the dosage of drug 'NIVOLUMAB'? | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | 3 MILLIGRAM/KILOGRAM, Q2WK | DrugDosageText | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
What was the outcome of reaction 'Hyponatraemia'? | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | Fatal | ReactionOutcome | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | Fatal | ReactionOutcome | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
What was the outcome of reaction 'Urosepsis'? | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | Fatal | ReactionOutcome | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune thrombocytopenia'. | Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren's Syndrome: When in Doubt, Use the PLASMIC Score.
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy due to an acquired autoantibody to ADA... | APIXABAN | DrugsGivenReaction | CC BY | 34887925 | 20,378,992 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Challenges in diagnosis and management of neonatal hyperparathyroidism in a resource-limited country: a case series from a Sudanese family.
Neonatal hyperparathyroidism is a rare disease caused by a homozygous inactivating mutation in the calcium sensing receptor gene. It presents early in life with life threatening ma... | CALCITONIN, FUROSEMIDE | DrugsGivenReaction | CC BY | 34887979 | 20,953,773 | 2021 |
What is the weight of the patient? | Challenges in diagnosis and management of neonatal hyperparathyroidism in a resource-limited country: a case series from a Sudanese family.
Neonatal hyperparathyroidism is a rare disease caused by a homozygous inactivating mutation in the calcium sensing receptor gene. It presents early in life with life threatening ma... | 6 kg. | Weight | CC BY | 34887979 | 20,953,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cervix disorder'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoperitoneum'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pelvic haematoma'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock haemorrhagic'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Uterine rupture'. | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | MISOPROSTOL | DrugsGivenReaction | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the administration route of drug 'MISOPROSTOL'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Vaginal | DrugAdministrationRoute | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the outcome of reaction 'Cervix disorder'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Recovered | ReactionOutcome | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the outcome of reaction 'Haemoperitoneum'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Recovered | ReactionOutcome | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the outcome of reaction 'Pelvic haematoma'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Recovered | ReactionOutcome | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the outcome of reaction 'Shock haemorrhagic'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Recovered | ReactionOutcome | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
What was the outcome of reaction 'Uterine rupture'? | A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion.
The use of misoprostol in the second trimester by a woman with a uterine scar may lead to severe contractions and uterine rupture. We report a 24-year-old pregnant female patient who presented at the Emergency Dep... | Recovered | ReactionOutcome | CC BY-ND | 34888091 | 20,311,147 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cavernous sinus thrombosis'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cellulitis orbital'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,506,239 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucormycosis'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,506,239 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital abscess'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhinocerebral mucormycosis'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinusitis'. | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34888198 | 20,499,508 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | UNK (SYSTEMIC) | DrugDosageText | CC BY | 34888198 | 20,499,508 | 2021 |
What was the outcome of reaction 'Cellulitis orbital'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovering | ReactionOutcome | CC BY | 34888198 | 20,499,508 | 2021 |
What was the outcome of reaction 'Mucormycosis'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 34888198 | 20,506,239 | 2021 |
What was the outcome of reaction 'Osteonecrosis'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovering | ReactionOutcome | CC BY | 34888198 | 20,499,508 | 2021 |
What was the outcome of reaction 'Periorbital abscess'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovering | ReactionOutcome | CC BY | 34888198 | 20,499,508 | 2021 |
What was the outcome of reaction 'Rhinocerebral mucormycosis'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovering | ReactionOutcome | CC BY | 34888198 | 20,499,508 | 2021 |
What was the outcome of reaction 'Sinusitis'? | Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report.
Mucormycosis, a rare fungal infection, mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to tha... | Recovering | ReactionOutcome | CC BY | 34888198 | 20,499,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34888240 | 20,340,848 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34888240 | 20,340,848 | 2021 |
What was the administration route of drug 'CAPECITABINE'? | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | Oral | DrugAdministrationRoute | CC BY | 34888240 | 20,340,848 | 2021 |
What was the dosage of drug 'CAPECITABINE'? | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | ON DAYS 1-14, FIVE CYCLES | DrugDosageText | CC BY | 34888240 | 20,340,848 | 2021 |
What was the dosage of drug 'OXALIPLATIN'? | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | ON DAY 1, FIVE CYCLES | DrugDosageText | CC BY | 34888240 | 20,340,848 | 2021 |
What was the outcome of reaction 'Disease progression'? | An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.
Mutations in KRAS (codon 12/13), NRAS, BRAF V600E, and amplification of ERBB2 and MET account for 70-80% of anti-epidermal growth factor receptor (... | Not recovered | ReactionOutcome | CC BY | 34888240 | 20,340,848 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Aortic Root Thrombus Directly After Left Ventricular Assist Device Implantation.
A 70-year-old female heart failure patient could not be weaned from temporary left ventricular mechanical support with Impella CP (Abiomed Inc, Danvers, MA) after myocardial infarction; therefore, she underwent left ventricular assist devi... | HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34888513 | 20,314,373 | 2021-10 |
What was the administration route of drug 'HEPARIN SODIUM'? | Aortic Root Thrombus Directly After Left Ventricular Assist Device Implantation.
A 70-year-old female heart failure patient could not be weaned from temporary left ventricular mechanical support with Impella CP (Abiomed Inc, Danvers, MA) after myocardial infarction; therefore, she underwent left ventricular assist devi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34888513 | 20,314,373 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaesthetic complication pulmonary'. | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | AMPICILLIN SODIUM\SULBACTAM SODIUM, FENTANYL, PROPOFOL, RANITIDINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchospasm'. | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | AMPICILLIN SODIUM\SULBACTAM SODIUM, FENTANYL, PROPOFOL, RANITIDINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | AMPICILLIN SODIUM\SULBACTAM SODIUM, FENTANYL, PROPOFOL, RANITIDINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | AMPICILLIN SODIUM\SULBACTAM SODIUM, FENTANYL, PROPOFOL, RANITIDINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wheezing'. | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | AMPICILLIN SODIUM\SULBACTAM SODIUM, FENTANYL, PROPOFOL, RANITIDINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
What is the weight of the patient? | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | 52 kg. | Weight | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
What was the administration route of drug 'RANITIDINE HYDROCHLORIDE'? | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | Oral | DrugAdministrationRoute | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
What was the outcome of reaction 'Vomiting'? | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | Recovered | ReactionOutcome | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
What was the outcome of reaction 'Wheezing'? | Esophageal achalasia detected by vomiting during induction of general anesthesia: a case report.
BACKGROUND
Esophageal achalasia is a rare disease with a high risk of aspiration during anesthesia induction. Here, we describe our experience involving a case of undiagnosed esophageal achalasia with profuse vomiting durin... | Recovered | ReactionOutcome | CC BY | 34888750 | 20,340,938 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | LORAZEPAM, VENLAFAXINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34889278 | 20,434,116 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | LORAZEPAM, VENLAFAXINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34889278 | 20,350,114 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | LORAZEPAM, VENLAFAXINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34889278 | 20,434,116 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver injury'. | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | LORAZEPAM, VENLAFAXINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34889278 | 20,671,647 | 2021-12-10 |
What was the outcome of reaction 'Drug interaction'? | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | Recovered | ReactionOutcome | CC BY | 34889278 | 20,434,116 | 2021-12-10 |
What was the outcome of reaction 'Drug-induced liver injury'? | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | Recovered | ReactionOutcome | CC BY | 34889278 | 20,350,114 | 2021-12-10 |
What was the outcome of reaction 'Hepatitis'? | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | Recovered | ReactionOutcome | CC BY | 34889278 | 20,434,116 | 2021-12-10 |
What was the outcome of reaction 'Liver injury'? | Early intervention of acute liver injury related to venlafaxine: A case report.
BACKGROUND
Drug-induced liver injury (DILI) is the leading cause of acute liver injury (ALI), market withdrawal of a drug, and rejection of applications for marketing licenses. The incidence of DILI is very low, with a value between 1 and 1... | Recovered | ReactionOutcome | CC BY | 34889278 | 20,671,647 | 2021-12-10 |
What was the administration route of drug 'NIVOLUMAB'? | Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
BACKGROUND
Concern for immune-related adverse events from immunotherapy and radiation therapy are well-documented; however, side effects are mostly mild to moderate. Howe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34889301 | 20,235,476 | 2021-12-10 |
What was the dosage of drug 'BETAMETHASONE DIPROPIONATE'? | Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
BACKGROUND
Concern for immune-related adverse events from immunotherapy and radiation therapy are well-documented; however, side effects are mostly mild to moderate. Howe... | 0.05 UNK | DrugDosageText | CC BY | 34889301 | 20,235,476 | 2021-12-10 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
BACKGROUND
Concern for immune-related adverse events from immunotherapy and radiation therapy are well-documented; however, side effects are mostly mild to moderate. Howe... | 0.9 PERCENT 100 ML | DrugDosageText | CC BY | 34889301 | 20,359,322 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Compression fracture'. | A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
OBJECTIVE
GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematop... | BUSULFAN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE | DrugsGivenReaction | CC BY | 34893945 | 20,568,180 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytopenia'. | A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
OBJECTIVE
GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematop... | BUSULFAN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE | DrugsGivenReaction | CC BY | 34893945 | 20,568,180 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteoporosis'. | A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
OBJECTIVE
GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematop... | BUSULFAN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE | DrugsGivenReaction | CC BY | 34893945 | 20,568,180 | 2021-12-10 |
What was the dosage of drug 'BUSULFAN'? | A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
OBJECTIVE
GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematop... | 8 MG/KG | DrugDosageText | CC BY | 34893945 | 20,568,180 | 2021-12-10 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
OBJECTIVE
GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematop... | 150 MG/M2 | DrugDosageText | CC BY | 34893945 | 20,568,180 | 2021-12-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Antineutrophil cytoplasmic antibody'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,219,541 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal haemorrhage'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary vasculitis'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,219,541 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
What was the dosage of drug 'PACLITAXEL'? | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | QW (SCHEDULED FOR 12 WEEKS OF PACLITAXEL WEEKLY) | DrugDosageText | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
What was the outcome of reaction 'Interstitial lung disease'? | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | Recovering | ReactionOutcome | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
What was the outcome of reaction 'Respiratory failure'? | The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.
Targeted therapies agains... | Recovering | ReactionOutcome | CC BY-NC-ND | 34894465 | 20,546,303 | 2021-11-29 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.